• Health Industries: U.S. Outlook for 2025 and Beyond

  • Jan 6 2025
  • Length: 25 mins
  • Podcast

Health Industries: U.S. Outlook for 2025 and Beyond

  • Summary

  • Tune in to listen as PwC’s leaders Roel van den Akker and Nick Donkar provide insights into the 2024 deals landscape and offer a preview of what lies ahead. Topics include:

    Key topics include:

    • A look back at M&A activity in health industries in 2024
    • The challenges and potential impediments that could affect deal volumes in the coming year
    • How artificial intelligence and tech innovations are reshaping the volume and nature of healthcare transactions
    • Key trends and developments to watch for with emphasis on growth, strategic assessments and regulatory factors


    Speakers:
    Roel van den Akker, Pharmaceutical and Life Sciences Deals Leader, PwC
    Nick Donkar, Health Services Deals Leader, PwC
    Jenny Colapietro, Consulting Commercial Leader, PwC

    Linked materials:

    • https://www.pwc.com/us/en/industries/health-industries/library/health-services-deals-outlook.html
    • https://www.pwc.com/us/en/industries/health-industries/library/pharma-life-sciences-deals-outlook.html


    For more information, please visit us at: https://www.pwc.com/us/en/industries/health-industries/health-research-institute/next-in-health-podcast.html.

    Show more Show less

What listeners say about Health Industries: U.S. Outlook for 2025 and Beyond

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.